BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22951096)

  • 21. Progress towards personalized medicine.
    Bates S
    Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in bacterial transcriptome and transposon insertion-site profiling using second-generation sequencing.
    Febrer M; McLay K; Caccamo M; Twomey KB; Ryan RP
    Trends Biotechnol; 2011 Nov; 29(11):586-94. PubMed ID: 21764162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptomics and venomics: implications for medicinal chemistry.
    Ducancel F; Durban J; Verdenaud M
    Future Med Chem; 2014 Oct; 6(15):1629-43. PubMed ID: 25406004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH
    Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosis.
    Villoslada P; Baranzini S
    J Neuroimmunol; 2012 Jul; 248(1-2):58-65. PubMed ID: 22281286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoinformatics and systems biology methods for personalized medicine.
    Yan Q
    Methods Mol Biol; 2010; 662():203-20. PubMed ID: 20824473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomics and personalized medicine.
    Sadee W
    Int J Pharm; 2011 Aug; 415(1-2):2-4. PubMed ID: 21539903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next-generation sequencing technologies for personalized medicine: promising but challenging.
    Chen G; Shi T
    Sci China Life Sci; 2013 Feb; 56(2):101-3. PubMed ID: 23393024
    [No Abstract]   [Full Text] [Related]  

  • 32. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personalized medicine policy challenges: measuring clinical utility at point of care.
    van Rooij T; Wilson DM; Marsh S
    Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):289-95. PubMed ID: 22812553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalized medicine: changing the paradigm of drug development.
    Couch RD; Mott BT
    Methods Mol Biol; 2012; 823():367-78. PubMed ID: 22081358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biomarkers: "Found in translation"].
    Lockhart BP; Walther B
    Med Sci (Paris); 2009 Apr; 25(4):423-30. PubMed ID: 19409197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of omic technologies on the study of food microbes.
    O'Flaherty S; Klaenhammer TR
    Annu Rev Food Sci Technol; 2011; 2():353-71. PubMed ID: 22129387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.
    Marquardt JU; Galle PR; Teufel A
    J Hepatol; 2012 Jan; 56(1):267-75. PubMed ID: 21782758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward?
    Patwardhan B; Mashelkar RA
    Drug Discov Today; 2009 Aug; 14(15-16):804-11. PubMed ID: 19477288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Impacts of modern biology on drug discovery].
    Guo JB; Li XJ
    Sheng Li Ke Xue Jin Zhan; 2007 Jan; 38(1):25-31. PubMed ID: 17438949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.